Paul Corso

Impact of Continued Hospitalization in Patients Pre-treated with Clopidogrel Prior to Coronary Angiography and Undergoing Corona

08/01/2008

Ron Waksman , MD;

William O. Suddath , MD;

Lowell F. Satler , MD;

Seung-Woon Rha , MD, PhD;

Kenneth M. Kent , MD, PhD;

Augusto D. Pichard , MD, FACC, FSCAI;

Pramod K. Kuchulakanti , MD;

Edouard Cheneau , MD;

Robert Lew , MD;

Rajbabu Pakala , MD, PhD;

Emmanouil I. Kapetanakis ;

Elizabeth Haile ;

Paul Corso ;

Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...

Clopidogrel is an oral...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Paul Corso

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products